For the first quarter of the fiscal year ending March 2027, net sales were JPY 174.4 billion, up 117.5% YoY. Operating income was JPY 41.0 billion, ordinary income was JPY 39.5 billion, and net income attributable to owners of the parent was JPY 26.3 billion, all exceeding the prior year’s figures. Strengthening measures in the Medical business and AI technology initiatives are expanding the growth foundation for this term. See main body for segment details.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3937","jir_company_name":"Ubicom Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3937-20260813-02.pdf","jir_short_summary":"For the first quarter of the fiscal year ending March 2027, net sales were JPY 174.4 billion, up 117.5% YoY. Operating income was JPY 41.0 billion, ordinary income was JPY 39.5 billion, and net income attributable to owners of the parent was JPY 26.3 billion, all exceeding the prior year's figures. Strengthening measures in the Medical business and AI technology initiatives are expanding the growth foundation for this term. See main body for segment details.","jir_summary":"### Performance overview\nFor the first quarter of the fiscal year ending March 2027, net sales were 1,744 million yen, operating income 410 million yen, ordinary income 395 million yen, and net income 263 million yen. Compared with the same period last year, net sales expanded significantly (YoY 117.5% increase), with substantial gains in operating income and ordinary income. New initiatives include expanding the Medical business, reinforcing direct sales of the Mighty series, and advancing AI technology utilization.\n\n### Outlook and initiatives\nBy advancing the AI Technology strategy and strengthening the M&A strategy, we aim for sustained improvement in sales and profitability. Efforts include expanding the Medical business, promoting group-wide integration such as Radiance Wear, strengthening the Clinical IT field, and expanding the sales channels for the Mighty series to fortify the growth foundation.","jir_financial_highlights":"Net sales: 1,744 \u767e\u4e07\u5186 (YoY 117.5% increase)\nOperating income: 410 \u767e\u4e07\u5186 (YoY 30.9% increase)\nOrdinary income: 395 \u767e\u4e07\u5186 (YoY 25.0% increase)\nNet income attributable to owners of parent: 263 \u767e\u4e07\u5186 (YoY -8 \u65e5\u672c\u8a9e\u8868\u8a18\u4e0d\u53ef -)","jir_category":"","jir_hashtags":"#ShareBuybackRelated, #ExecutiveAppointmentsRelated","jir_key_figures":"Net sales: 1,744 \u767e\u4e07\u5186\nOperating income: 410 \u767e\u4e07\u5186\nOrdinary income: 395 \u767e\u4e07\u5186","jir_meta_title":"Ubicom Holdings, Inc. 1Q FY2027 Financial Results | Net sales 1,744 hundred million yen, up 117.5% YoY","jir_meta_description":"Key points of Ubicom's 1Q FY2027 financial results. Net sales 1,744 million yen, operating income 410 million yen, ordinary income 395 million yen, net income 263 million yen. Growth strategy through expansion in AI and Medical areas and strengthening of the Mighty series.","jir_og_title":"Ubicom Holdings 1Q FY2027 Highlights","jir_og_description":"Ubicom's Q1 results show net sales of 1,744 million yen, up 117.5% YoY. Introduces expansion in AI and medical businesses and enhanced Mighty series sales strategy.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net sales trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 1Q\\\",\\\"FY2027 1Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net sales\\\",\\\"data\\\":[1744,1744]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating income trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 1Q\\\",\\\"FY2027 1Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating income\\\",\\\"data\\\":[263,410]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Profit margin analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":[[\\\"Net sales\\\", \\\"Margin\\\"],[\\\"FY2026 1Q\\\", \\\"-\\\"],[\\\"FY2027 1Q\\\", \\\"-\\\"]]}\"}]","ir_related_company":58603,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-103531","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n